The Oxytocin Study
The purpose of this study is to investigate a new administration method of the already approved drug Oxytocin. Oxytocin is a hormone that is given to women in childbirth to prevent Postpartum Haemorrhage (PHH).
Oxytocin is the standard treatment in preventing PPH. If this delivery method is successful this could increase access to this lifesaving treatment for women in the developing world, who do not have access to current approved versions due to the storage and administrative method.
PPH is one of the major public health problems in the developing world and kills approximately 60,000 women each year.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!